News Releases

News Releases

Feb 08, 2021
Annexon Welcomes William H. Carson, M.D. to the Board of Directors
Thomas G. Wiggans appointed Chairman SOUTH SAN FRANCISCO, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Annexon, Inc.  (“Annexon”) (Nasdaq: ANNX), a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and
Additional Formats
Jan 05, 2021
Annexon to Present at the J.P. Morgan 39th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain
Additional Formats

Investor Tools